Vitrolife AB

47
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0011205202
SEK
139.20
-5.5 (-3.8%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Vitrolife AB Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
674.00
-3,712.00
537.00
459.00
366.00
492.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-68.00
-119.00
-175.00
-10.00
9.00
-61.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
907.00
757.00
636.00
384.00
356.00
413.00
Cash Flow from Investing Activities
-377.00
-124.00
-144.00
-6,518.00
-20.00
-112.00
Cash Flow from Financing Activities
-286.00
-300.00
-582.00
5,748.00
-26.00
-106.00
Net Cash Inflow / Outflow
273.00
283.00
-51.00
-343.00
284.00
198.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
29.00
-50.00
39.00
42.00
-25.00
4.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in SEK Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Vitrolife AB
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Profit Before Tax
674
490
184.00
37.55%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-68
-203
135.00
66.50%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
907
2626
-1,719.00
-65.46%
Cash Flow from Investing Activities
-377
-1672
1,295.00
77.45%
Cash Flow from Financing Activities
-286
-607
321.00
52.88%
Net Cash Inflow / Outflow
273
177
96.00
54.24%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
29
-170
199.00
117.06%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 19.82% vs 19.03% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
907.00
757.00
19.82%